The Economic Impact of Managing Late Presentation of Developmental Dysplasia of Hip (DDH)
Rim Anuar, H P Mohd-Hisyamudin, M H Ahmad, O Zulkiflee, Rim Anuar, H P Mohd-Hisyamudin, M H Ahmad, O Zulkiflee
Abstract
Delayed presentation of Developmental Dysplasia of Hip (DDH) comes with challenges in treatment as well as high surgical cost. Therefore the objective of this study is to quantify the economic impact of management of late presentation of DDH during a last 3-year period. We conducted a retrospective study with analysis of DDH cases managed between years 2012 to 2014. Early and late presentations of DDH were identified and cost management for both was estimated. Out of twenty-four DDH cases, thirteen cases fulfilled the inclusion criteria. All were female with majority of them presenting with unilateral DDH predominantly of the left hip. Most patients presented after age of six months and the principal complaint was abnormal or limping gait. The grand total cost for managing DDH during the three years period was USD 12,385.51, with 86% of the amount having been used to manage late presentation of DDH that was mostly contributed by the cost of surgery. We concluded that delayed presentation of DDH contributes heavily to high national expenditure. Early detection of DDH cases with systematic neonatal screening may help to minimize the incidence of the late presenting DDH and subsequently reduce the economic burden to the government.
Keywords: DDH; Economic impact; late presentation.
References
- Sengupta S. Congenital dislocation of hip in Malaysia. Indian J Surg. 1973;35(7):322–6.
- Boo NY, Rajaram T. Congenital dislocation of hips in Malaysia neonates. Sing Med J. 1989;30:368–71.
- Rebello G, Joseph B. Late presentation of developmental dysplasia of the hip in children from southwest India – Will screening help? Indian J Orthop. 2003;37:210–4.
- Asim AM, Saw A, Nawar M. Treatment of Developmental Dysplasia of the Hip: Short and Mid-term Outcome. Malays Orthop J. 2011;5(1):17–20.
- Tredwell SJ. Neonatal screening for hip joint instability. Its clinical and economic relevance. Clin Orthop Relat Res. 1992;(281):63–8.
- Fees (Medical) (Amendment) Order. 2003 P.U(A) 6/2003: 235-1112.
- Logistic Pharmacy Store (Non-medication Registry). Department of Pharmacy, Penang Hospital. 2015:1–19.
- Full Paying Patient (FPP) Guideline. Modified 2015 Ministry of Health of Malaysia. 2007.
- Medical Registry. Integration Store Unit. Department of Pharmacy, Penang Hospital. 2014:2–7.
- Gul R, Coffey JC, Khayyat G, McGuinness AJ. Late presentation of developmental dysplasia of the hip. Irish J Med Sc. 2002;171(3):139–40.
- Clarke NMl, Reading IC, Corbin C, Taylor CC, Bochmann T. Twenty years experience of selective secondary ultrasound screening for congenital dislocation of the hip. Arch Dis Child. 2012;97(5):423–9.
- Cady RB. Developmental dysplasia of the hip: definition, recognition, and prevention of late sequelae. Pediatr Ann. 2006;35(2):92–101.
Source: PubMed